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Abstract
 .  .High intracellular 1,2,-sn-diacylglycerol DAG usually activates protein kinase C PKC . In choline-deficient Fischer
344 rats, we previously showed that fatty liver was associated with elevated hepatic DAG and sustained activation of PKC.
Steatosis is a sequelae of many liver toxins, and we wanted to determine whether fatty liver is always associated with
accumulation of DAG with activation of PKC. Obese Zucker rats had 11-fold more triacylglycerol in their livers and 2-fold
more DAG in their hepatic plasma membrane than did lean control Zucker rats. However, this increased diacylglycerol was
not associated with translocation or activation of PKC in hepatic plasma membrane activity in obese rats was 897
y1 y1 .pmolrmg protein=min vs. 780 pmolrmg protein=min in lean rats . No differences in PKC isoform expression
were detected between obese and lean rats. In additional studies, we found that choline deficiency in the Zucker rat did not
result in activation of PKC in liver, unlike our earlier observations in the choline deficient Fischer rat. This dissociation
between fatty liver, DAG accumulation and PKC activation in Zucker rats supports previous reports of abnormalities in
PKC signaling in this strain of rats. q 1997 Elsevier Science B.V.
 .Keywords: Protein kinase C; Diacylglycerol; Liver; Zucker rat
1. Introduction
 .1,2-sn-diacylglycerol DAG is an important inter-
mediate for the biosynthesis of triacylglycerol and
w xmembrane phospholipids 1 . It is also a second
messenger formed transiently in plasma membrane
 .where it can activate protein kinase C PKC , causing
the enzyme to translocate from the cytosol to mem-
) Corresponding author. Fax: q1 919 9667216. E-mail:
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w xbranes 2,3 . Prolonged activation of PKC is associ-
w xated with mitogenesis and cell transformation 4–6 .
Choline is a nutrient which is a precursor for the
biosynthesis of acetylcholine and the choline-phos-
w xpholipids 7 . It is also the major dietary source for
w xlabile methyl-groups 7 . Rats fed diets devoid of
choline accumulate triacylglycerol in their livers due
to the inhibition of very-low-density lipoprotein
 . w xVLDL secretion 8,9 . The fatty liver of choline
deficiency in the Fischer 344 rat was associated with
hepatic accumulation of DAG and activation as well
w xas overexpression of PKCa and d 10–12 . Is this
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true of other types of fatty livers? If so, this would
have important implications for human disease be-
cause fatty liver is a common clinical problem. Obese
w xZucker rats accumulate fat in their liver 13,14 and
an abstract has reported increased diacylglycerol in
w xliver 15 . These rats have a single autosomal reces-
w xsive gene mutation that induces obesity 16 . They are
hyperphagic, hypertriglyceridemic, and hyperinsu-
w xlinemic 16 . We used obese Zucker rats to determine
whether this type of fatty liver was associated with
increased DAG and activation of PKC.
2. Materials and methods
2.1. Animals
Animal care was in accordance with guidelines of
National Institutes of Health and institutional guide-
lines of the University of North Carolina at Chapel
Hill. Obese and lean male Zucker rats 12 weeks old;
.Charles River Breeders, Wilmington, MA were fed
Prolab Rodent Chow 3000 Agway County Food
.Inc., Syracuse, NY for 5 weeks. To determine ef-
fects of choline deficiency, obese male Zucker rats or
age matched male Fischer 344 rats Charles River
.Breeders, Wilmington, MA were fed a semisynthetic
choline sufficient diet Lombardi diet, Dyets, Beth-
.lethem, PA for 1 week, and then fed choline suffi-
cient or choline deficient diets for 2 weeks. Water
and diets were offered ad libitum. Animals were
anesthetized with ether, and a sample of liver was
collected and chilled on ice for immediate use in
subcellular fractionation. A lobe of liver was also
collected by freeze-clamping with tongs cooled in
liquid nitrogen and was stored at y808C until used
for analyses.
2.2. Subcellular fractionation
2 gm of the fresh livers were homogenized in 0.25
M sucrose buffer containing 20 mM Tris, 0.5 mM
EGTA, 2 mM EDTA, 2 mM MgCl , 0.1% Aprotinin,2
20 mM leupeptin, 0.1 mM n-tosyl-L-phenylalanine
chloromethyl ketone, 5 mM dithiothreitol, 1 mM
phenylmethylsulfonylfluoride, pH 8.0. Plasma mem-
brane, delipidated cytosol, and lipid droplet fractions
w xwere prepared 11 and enzyme markers were mea-
w xsured to check the purity of each fraction 10 .
2.3. Triacylglycerol and diradylglycerol analysis
Lipids were extracted from liver homogenates or
w xsubcellular fractions of liver 17 . Hepatic triacyl-
glycerol was isolated by thin layer chromatography
 .  .TLC hexanerethyl etherracetic acid, 50:50:1 , hy-
drolyzed and measured as fatty acid methyl esters
w xusing capillary gas chromatography 18 . Triheptade-
canoin was used as an internal standard to correct for
 .variations in recovery. Diradylglycerol DRG was
determined by using diacylglycerol kinase and
w32 xP ATP to form radiolabeled phosphatidic acid,
which was then isolated by TLC chloroformrpyri-
. w xdiner88% formic acid, 60:30:7 19 , and quantitated
using an imaging radiometric scanner Bioscan,
.Washington, DC . This assay was specific for 1,2-sn-
DRG. The 1,2-sn-DRG standard Avanti Polar Lipids,
.Alabaster, AL used in the assay calculations was
periodically tested for acyl migration by TLC and gas
chromatography.
 .1-Alkyl-2-acylglycerol AAG was determined by
w32 xconverting the total DRG to P phosphatidic acid
using diacylglycerol kinase and then adding 500 units
 .of Rhizopus lipase Sigma for 30 min at 378C to
selectively destroy the diacylglycerol derivative pre-
sent. The radiolabeled 1-alkyl-lysophosphatidic acid
was then quantitated as described earlier. Amounts of
AAG were calculated by comparison with analyses of
authentic standard synthesized from 1-O-alkyl-2-
oleoyl-sn-glycero-3-phosphocholine using phospholi-
pase C and purified with a C18 cartridge Sep-Pak;
.Waters Associates, Milford, MA . Diacylglycerol
 .DAG was determined as the difference between
w xtotal DRG and AAG measurements 11 . Protein was
w xmeasured 20 using bovine serum albumin as stan-
dard.
2.4. Choline metabolite assay
Choline metabolites were measured from liver
samples pulverized in liquid nitrogen. Briefly, livers
were extracted, and water soluble choline metabolites
were separated by high performance liquid chro-
 . 14matography HPLC after addition of C-labeled in-
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w2 xternal standards. H-methyl -internal standards of
each metabolites were also added to permit correction
for recovery after analysis of choline moiety by a gas
w xchromatography mass spectrometry assay 21 . Phos-
phatidylcholine was analyzed in the organic phase of
t h e l i v e r e x t r a c t , u s i n g T L C
 .chloroformrmethanolrwater, 65:30:4 , hydrolysis
and subsequent mass spectrometry analysis of choline
w x21 .
2.5. S-adenosylmethionine and S-adenosylhomocy-
steine assay
 .Hepatic S-adenosylmethionine SAM and S-
 .adenosylhomocysteine SAH , were extracted from
50 mg pulverized liver using 100 ml of 0.1 M acetate
 .buffer pH 6.0 and 75 ml of 40% TCA solution. The
extracts were washed three times with ether, and
stored at y808C until assayed. SAM and SAH were
w xseparated by HPLC 22 . The initial solvent contained
25 mM NaH PO , 10 mM 1-heptane sulfuric acid2 4
 .pH 3.2 , and 10% methanol. The SAM and SAH
were eluted from a C18 column Beckman, Ultras-
.phere, 4.6 mm=25 cm using a linear methanol
gradient up to 25%. Peak area responses were mea-
sured at 254 nm.
2.6. Protein kinase C assay and Western blotting
The PKC activity in plasma membrane and cytosol
fractions were assayed by measuring the transfer of
w32 x w 32 xP phosphate from g- P ATP to myelin basic pro-
w xtein 11 . The samples were solubilized with 1%
Nonidet P-40 and kept overnight at y808C. They
were thawed and incubated on ice with 1% CHAPSO.
After sonication, the samples were applied to a
DEAE-cellulose column equilibrated with buffer A
20 mM Tris-HCl buffer, pH 7.5, with 0.5 mM
.EDTA and 0.1 mM EGTA . PKC was eluted two
times using buffer A containing 0.18 M NaCl. Assay
tubes contained the following in a volume of 250
mL: 20 mM Tris-HCl, 0.1 mM CaCl , 10 mM MgCl ,2 2
50 mg myelin basic protein, 90 mg phosphatidylser-
ine, 100 pmol phorbol 12-myristate 13-acetate, 10
w 32 xmM ATP, and 0.34 mCi g- P ATP. Reactions were
incubated for 10 min at 308C and stopped by spotting
25 ml of reaction mixture to phosphocellulose paper
 .Whatman, 2.5 cm, P81 . The filters were dried,
washed three times in batch with 1% phosphoric acid,
and finally with 70% ethanol. Radioactivity of 32P on
the filters was determined by liquid scintillation spec-
 .trophotometry Pharmacia; Wallac 1410 . Protein ki-
nase C activity was expressed as pmol of 32P trans-
w 32 xferred from g- P ATP to substrate per minute per
mg of protein.
To measure PKC isoform amounts, 50–100 mg of
protein was subjected to 10% SDS-polyacrylamide
w xgel electrophoresis 23 . The separated proteins were
transferred by electroblotting onto nitrocellulose pa-
per. Nonspecific binding sites were blocked by incu-
bation with 5% nonfat dry milk in phosphate-buffered
saline. The nitrocellulose sheets were incubated with
the respective PKC antisera a , b II, d , and e ;
.CalBiochem, La Jolla, CA in either the presence or
absence of the respective antigen peptide. PKC bands
were visualized using ECL Amersham Life Science,
.Arlington Heights, IL .
3. Results
Liver weight in obese Zucker rats was almost
twice that seen in lean rats 23.5"5.1 g vs. 12.9"
.0.9 g; P-0.01 by unpaired t-test . Obese rats had
11-fold higher concentrations of triacylglycerol in
 .their livers 1737"187 nmolrmg protein compared
with lean animals 157"20 nmolrmg protein; P-
.0.001 by unpaired t-test . 1,2-DRG concentration in
liver was 4-fold higher in obese than in lean Zucker
 .rats Table 1 , with most of this additional DRG
associated with the intracellular lipid droplets that
accumulated in liver. Both DAG and AAG con-
 .tributed to this rise in DRG Table 1 . In hepatic
plasma membrane, DAG concentration was 2.8-fold
 .higher in obese than in lean animals Table 1 .
We observed no differences in the amounts of
 .cytosolic PKC inactive storage pool or membrane-
 .associated PKC activated between obese and lean
 .Zucker rats Table 2 . PKCa and b II isoforms were
not detected when 50 mg of plasma membrane pro-
tein was used for Western blotting. We detected d
and e isoforms, but there were no differences be-
 .tween obese and lean Zucker rats Fig. 1 . When we
used the specific PKCd and e peptide antigen to
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Table 1
Subclasses of 1,2-sn-diradylglycerol in livers from lean and obese Zucker rats
Lean Obese
DAG AAG DRG DAG AAG DRG
nmolrmg protein
)) )) ))Liver homogenate 2.4"0.2 0.53"0.06 2.9"0.2 11.0"1.2 1.3"0.1 12.2"1.3
Delipidated cytosol 0.21"0.00 n.d. 0.21"0.00 0.39"0.10 n.d. 0.39"0.10
)) ))Plasma membrane 6.9"0.6 2.4"0.6 9.3"1.0 19.0"1.9 3.0"0.2 22.0"1.8
nmolrgm liver
)) )) ))Lipid droplet 1.1"0.2 0.04"0.04 1.2"0.2 210"44 22.7"7.7 233"51
 .Lipids were extracted from liver homogenate or subcellular fractions of liver. 1,2-sn-Diradylglycerol DRG was determined by using
w32 xdiacylglycerol kinase and P ATP to form radiolabeled phosphatidic acid, which was isolated by TLC, and quantitated using an imaging
 .radiometric scanner. Alkyl-acyl-glycerols AAG were calculated by comparison with analysis of authentic standard. 1,2-sn-Di-
 .acylglycerol DAG was determined as the difference between total DRG and AAG measurement. Data were expressed as mean"S.E.M.
 . )) .ns5rgroup . Statistical difference was determined using unpaired t-test P-0.01 . n.d.snot detected.
compete with the antibodies for binding to the PKC
 .proteins, no PKC bands were found Fig. 2 which
confirmed the specific presence of PKCd and e in
the plasma membrane of these rat livers.
After Zucker rats ingested rodent chow, livers
from obese rats had more total choline moiety than
did lean controls slightly higher hepatic phos-
phatidylcholine concentratons, almost 2-fold higher
phosphocholine concentrations, and decreased choline
and glycerophosphocholine concentrations compared
.to lean controls; Table 3 . Obese Zucker rats had
higher concentrations of hepatic SAM 555"47
. pmolrmg protein compared with lean controls 381
."5 pmolrmg protein; Ps0.033 by unpaired t-test .
However, the SAMrSAH ratio an indication of
.methylating capacity was not significantly different
 .between obese 3.48"0.5 and lean Zucker rats
 .2.46"0.3; Ps0.115 by unpaired t-test .
When obese Zucker rats were fed semipurified
Table 2
Protein kinase C activity in livers from lean and obese Zucker
rats
Lean Zucker Obese Zucker P value
y1pmolrmg protein=min
Cytosol 456"39 445"41 0.855
Plasma membrane 780"70 897"46 0.158
w32 xPKC was assayed, by measuring the transfer of P phosphate
w 32 xfrom g- P ATP to myelin basic protein, in subcellular fractions
of liver from Zucker rats fed rodent chow. Data are expressed as
 .mean"S.E.M. ns5rgroup . Statistical difference was deter-
mined using unpaired t-test.
diets deficient in choline for 2 weeks, hepatic phos-
phatidylcholine concentration decreased to 142.2"
.6.2 nmolrmg protein compared with obese rats fed
choline sufficient diet 165.2"9.5 nmolrmg protein;
.Ps0.024 by unpaired t-test . Hepatic triacylglycerol
levels increased 2-fold in the choline deficient rats
 .1413"81 nmolrmg protein compared to the rats
fed a choline sufficient diet 601"85 nmolrmg
.protein , but there was no difference in the hepatic
DAG concentrations of the two obese groups 22"3
.vs. 21"1 nmolrmg protein . Choline content of the
diet did not influence plasma membrane PKC activity
Fig. 1. Expression of plasma membrane PKCd and e were
similar in livers from obese and lean Zucker rats. Obese and lean
male Zucker rats, 12 weeks old, were fed rodent chow for 5
weeks. The livers were then collected for isolation of plasma
membrane. Protein from plasma membrane fractions ns
.3rgroup was subjected to 10% SDS-polyacrylamide gel elec-
trophoresis. The separated proteins were transferred by elec-
troblotting onto nitrocellulose paper. Non-specific binding sites
were blocked by incubation with 5% nonfat dry milk in phos-
phate-buffered saline. The nitrocellulose sheet was incubated
 .with PKCd or PKCe antibody, and the PKC bands ;82 kDa
were visualized using ECL.
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Fig. 2. Choline deficiency did not change the expression of
PKCd and e in the plasma membrane of livers from obese
Zucker rats. Obese male Zucker rats were fed Lombardi choline
 .  .sufficient CS and deficient CD diets for 2 weeks, and livers
were collected for isolation of plasma membrane. Protein 100
.  .mg from liver plasma membrane fractions ns3rgroup was
subjected to 10% SDS-polyacrylamide gel electrophoresis. The
separated proteins were transferred by electroblotting onto nitro-
cellulose paper. Non-specific binding sites were blocked by
incubation with 5% non-fat dry milk in phosphate-buffered saline.
The nitrocellulose sheet was incubated with PKCd or PKCe
antibody, and the PKC bands were visualized using ECL. In
order to show specificity, plasma membrane proteins were sepa-
rated and incubated with the PKC antisera in the presence of the
 .peptide antigen pep before visualization of the PKC bands.
in the livers of obese Zucker rats choline sufficient,
1298"62 pmolrmg proteinrmin vs. choline defi-
cient, 1107"174 pmolrmg proteinrmin; Ps0.274
.by unpaired t-test . In a previous publication we
reported that hepatic DAG levels increased with
Table 3
Choline metabolite concentrations in livers from lean and obese
Zucker rats
Lean Obese P value
nmolrmg protein
Choline 0.85"0.15 0.49"0.05 0.006
Phosphocholine 8.5"0.7 16.1"2.1 0.017
Glycerophosphocholine 9.5"0.9 6.3"0.4 0.008
Phosphatidylcholine 141"9 181"18 0.076
Total choline moieties 160"10 204"22 0.074
Choline metabolites were measured in liver samples pulverized in
liquid N . Livers were extracted, and water soluble choline2
metabolites were separated by HPLC and choline moiety was
measured by a GC-MS assay. Phosphatidylcholine was separated
from organic phase of liver extracts, using TLC, hydrolyzed and
measured using the GC-MS assay. Data are expressed as mean"
 .S.E.M. ns5rgroup . Statistical difference was determined us-
ing unpaired t-test.
Fig. 3. Expression of PKCd was increased in the plasma mem-
brane of choline-deficient fatty livers from Fischer 344 rats. Male
 .Fischer 344 rats were fed Lombardi choline sufficient CS and
 .deficient CD diets for 2 weeks, and livers were collected for
isolation of plasma membrane. Protein from liver plasma mem-
 .brane fractions ns3rgroup was subjected to 10% SDS-poly-
acrylamide gel electrophoresis. The separated proteins were
transferred by electroblotting onto nitrocellulose paper. Non-
specific binding sites were blocked by incubation with 5% non-fat
dry milk in phosphate-buffered saline. The nitrocellulose sheet
was incubated with PKCd antibody, and the PKC bands were
visualized using ECL.
choline deficiency, and plasma membrane PKC activ-
ity was 3373"271 pmolrmg proteinrmin in choline
sufficent Fischer 344 rats, vs. 4998"408 pmolrmg
 .proteinrmin P-0.01 in choline deficient Fischer
w x344 rats 24 . Plasma membrane PKCd expression
was not altered by choline deficiency in obese Zucker
rats Fig. 2; data from replicate experiment not
.shown , while it was greatly increased in Fischer 344
 .rats Fig. 3 . There was a slight decrease in PKCe
expression in the choline deficient obese rats com-
 .pared to the choline sufficient group Fig. 2 .
4. Discussion
Obese Zucker rats had fatty livers, but this was not
caused by choline deficiency or methyl-deficiency
obese animals had slightly larger choline and methyl
stores in liver than did mean controls; this has not
.been previously reported . Despite increased secre-
tion of VLDL in obese Zucker rats compared to lean
controls, it is thought that rates of triacyglycerol
synthesis are so great in the obese rats that they
outstrip capacity for lipoprotein export, and lipid
w xaccumulates in the liver 13,14,16 . Obese Zucker
rats accumulated DAG in hepatic plasma membrane
in amounts similar to that observed in choline defi-
w xcient fatty livers 10,11 . DAG is a precursor for
triacyglycerol synthesis, and increased levels of DAG
may be indicative of increased flux through this
synthetic pathway. In addition, increased levels of
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insulin in obese Zucker rats may enhance the produc-
tion of DAG secondary to increased phosphatidate
w xsynthesis and hydrolysis 25–27 .
Increased DAG concentration in plasma membrane
of livers from obese Zucker rats was not associated
 .with translocation and activation of PKC Table 2 .
Perhaps calcium-dependent isoforms of PKC may not
have been activated in the fatty liver from Zucker rats
w q2 xbecause Ca may not be elevated. However, noveli
calcium-independent isoforms such as d and e should
be activatable, and translocate to the plasma mem-
brane in response to the elevation in DAG content. In
earlier studies, using Fischer 344 rats, we showed
that elevations in hepatic plasma membrane DAG
occurred at 2 weeks on a choline-deficient diet, and
that elevated DAG was associated with sustained
w xactivation and overexpression of PKCa and d 24 .
Even when we made obese Zucker rats choline
deficient, we did not observe an added increase in
hepatic DAG concentrations nor did we observe acti-
vation of PKC. Clearly the fatty liver of the obese
Zucker rat differs from the fatty liver of the choline
deficient Fischer rat, and fatty infiltration of liver is
not always associated with activation of PKC. Possi-
bly, the elevated DAG in liver might not have the
appropriate fatty acid composition suitable for activa-
w xtion of PKC 28 , or is not being distributed to the
w xexact location needed on the plasma membrane 29 .
It is also possible that the activation of PKC is
impaired in the obese Zucker rats, or the PKCs from
these rats might be different from those of other rats.
In obese Zucker rat heart, basal PKC was unchanged,
but the PKC was abnormally distributed between the
cytosol and particulate fractions, and translocation of
w xthe enzyme was impaired 30 . Moreover, obese
Zucker rats express abnormal forms of PKC in mus-
w xcle 31 , and PKCs from obese Zucker rat liver and
heart were less sensitive to the PKC activator, phor-
w xbol myristate acetate, a DAG analog 32,33 .
We had hoped to clarify whether various forms of
fatty liver may be associated with DAG accumulation
and PKC activation in hepatic plasma membrane. We
found that DAG does accumulate in livers of obese
Zucker rats, but we did not observe activation of
PKC. We suggest that regulation of PKC activity
may be unusual in the Zucker rat, and that other
models of fatty liver need to be studied before we can
determine whether fatty liver is usually associated
with sustained activation of PKC.
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